These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of vestibular and cochlear ototoxicity from transtympanic streptomycin administration. Wanamaker HH; Slepecky NB; Cefaratti LK; Ogata Y Am J Otol; 1999 Jul; 20(4):457-64. PubMed ID: 10431887 [TBL] [Abstract][Full Text] [Related]
23. [Cochleovestibular lesions caused by daily overdosage of streptomycin for short periods of time]. GALIOTO GB Otorinolaringol Ital; 1955; 23(2):151-65. PubMed ID: 14394691 [No Abstract] [Full Text] [Related]
24. Vestibular apparatus intoxication of experimental animals with streptomycin and dihydrostreptomycin and mixtures. GRIZZLE C; CUTTING WC Acta Otolaryngol; 1953; 43(4-5):421-8. PubMed ID: 13104136 [No Abstract] [Full Text] [Related]
25. Neurotoxic symptoms in streptomycin therapy: a pilot trial of treatment with pantothenic acid. PENMAN AC; DICKSON I; MILLER JS Tubercle; 1957 Dec; 38(6):422-4. PubMed ID: 13519517 [No Abstract] [Full Text] [Related]
26. [Case of isolated lesion of the vestibular apparatus in a patient with pulmonary tuberculosis treated with streptomycin]. Obara K Otolaryngol Pol; 1971; 25(1):109-11. PubMed ID: 5313792 [No Abstract] [Full Text] [Related]
28. Diuretics in the management of streptomycin induced vestibular damage. Singh RB J Assoc Physicians India; 1977 Aug; 25(8):581-2. PubMed ID: 306993 [No Abstract] [Full Text] [Related]
29. Ototoxic interactions of ethacrynic acid and streptomycin. Mathog RH; Capps MJ Ann Otol Rhinol Laryngol; 1977; 86(2 pt. 1):158-63. PubMed ID: 300585 [TBL] [Abstract][Full Text] [Related]
30. [Electron microscopic studies of acid phosphatase activity in the vestibular apparatus (with special reference to the damage caused by streptomycin sulfate)]. Nakamura F; Takenaka B; Hama H; Suzuki M; Hirayama M Nihon Jibiinkoka Gakkai Kaiho; 1968 Mar; 71(3):294-9. PubMed ID: 5302914 [No Abstract] [Full Text] [Related]
31. [Relative toxicity of streptomycin and dihydrostreptomycin in prolonged therapy]. BJERRE-CHRISTENSEN K; KIØRBOE F Nord Med; 1953 Oct; 50(43):1463-4. PubMed ID: 13111562 [No Abstract] [Full Text] [Related]
32. Clinical problems pertaining to neurotoxicity of streptomycin group of drugs. WINSTON J AMA Arch Otolaryngol; 1953 Jul; 58(1):55-61. PubMed ID: 13057452 [No Abstract] [Full Text] [Related]
33. [Injuries of stato-acoustic apparatus following streptomycin administration]. FEMENIC B; SALAJ B Tuberkuloza; 1952; 4(5-6):511-29. PubMed ID: 13049589 [No Abstract] [Full Text] [Related]
34. Ototoxicity of a mixture of streptomycin and dihydrostreptomycin: a preliminary report. LUMSDEN EG; POWELL RJ Tubercle; 1953 Dec; 34(12):324-30. PubMed ID: 13122766 [No Abstract] [Full Text] [Related]
35. Factors influencing results with streptomycin perfusion of the labyrinth. Shea JJ; Ge X Am J Otol; 1993 Nov; 14(6):570-5. PubMed ID: 8296861 [TBL] [Abstract][Full Text] [Related]
36. Clinical research experience with gentamicin. Incidence of adverse reactions. Arcieri GM; Falco FG; Smith HM; Hobson LB Med J Aust; 1970 Jun; 1():Suppl:30-4. PubMed ID: 5311183 [No Abstract] [Full Text] [Related]
37. Frusemide in the management of streptomycin induced vestibular damage. Purohit SD; Bomb BS; Sharma GS Indian J Chest Dis Allied Sci; 1976 Apr; 18(2):111-3. PubMed ID: 800016 [No Abstract] [Full Text] [Related]
38. [Vestibular analyzer in patients with hearing disorders occurring after antibiotic therapy]. Petrova EI Vestn Otorinolaringol; 1971; 33(4):15-9. PubMed ID: 4939448 [No Abstract] [Full Text] [Related]
39. Acute and chronic effects of streptomycin applied to the lateral semicircular canal. Norris CH; Aubert A; Amedee RG Am J Otol; 1993 Jul; 14(4):373-9. PubMed ID: 8238274 [TBL] [Abstract][Full Text] [Related]